| Exosomes as theranostic targets: Implications for the clinical prognosis of aggressive cancers R Gulati, D Nandi, K Sarkar, P Venkataraman, KM Ramkumar, P Ranjan, ... Frontiers in Molecular Biosciences 9, 890768, 2022 | 10 | 2022 |
| Exploring the CRISPR/Cas9 system in targeting drug resistant cancer stem cells R Gulati, MN Ramavath, VSMK Metta, SL Pandrangi Annals of the Romanian Society for Cell Biology 25 (6), 20540-20555, 2021 | 7 | 2021 |
| Prospecting of exosomal-miRNA signatures as prognostic marker for gestational diabetes mellitus and other adverse pregnancy outcomes T Mitra, R Gulati, A Uppal, SR Kumari, S Tripathy, P Ranjan, ... Frontiers in Endocrinology 14, 1097337, 2023 | 4 | 2023 |
| Endocrine disrupting chemicals: gestational diabetes and beyond T Mitra, R Gulati, K Ramachandran, R Rajiv, EAL Enninga, CK Pierret, ... Diabetology & Metabolic Syndrome 16 (1), 95, 2024 | | 2024 |
| Exosomal microRNAs in breast cancer: towards theranostic applications R Gulati, T Mitra, R Rajiv, EJE Rajan, C Pierret, EAL Enninga, ... Frontiers in Molecular Biosciences 11, 1330144, 2024 | | 2024 |
| Prospecting the theragnostic potential of the psycho-neuro-endocrinological perturbation of the gut-brain-immune axis for improving cardiovascular diseases outcomes EJE Rajan, SV Alwar, R Gulati, R Rajiv, T Mitra, R Janardhanan Frontiers in Molecular Biosciences 10, 1330327, 2024 | | 2024 |
| Binary Classification of Mammograms Using Horizontal Visibility Graph A Ghosh, P Ranjan, NS Chilamkurthy, R Gulati, R Janardhanan, ... Intelligent Systems and Applications: Select Proceedings of ICISA 2022, 351-361, 2023 | | 2023 |
| Clinical resource allocation for the mitigation of elder abuse D Nandi, R Gulati, T Mitra, P Ranjan, R Janardhanan The Lancet Healthy Longevity 3 (10), e649, 2022 | | 2022 |
| Improving services to tackle the syndemic of HIV and mental ill health D Nandi, M Reddy, R Gulati, A Saravanan, R Janardhanan The Lancet HIV 9 (10), e674, 2022 | | 2022 |
